首页> 外文期刊>Acta oncologica. >Heavy resistance training and lymphedema: Prevalence of breast cancer-related lymphedema in participants of an exercise intervention utilizing heavy load resistance training
【24h】

Heavy resistance training and lymphedema: Prevalence of breast cancer-related lymphedema in participants of an exercise intervention utilizing heavy load resistance training

机译:重阻力训练和淋巴水肿:采用重负荷阻力训练的运动干预参与者中与乳腺癌相关的淋巴水肿的患病率

获取原文
获取原文并翻译 | 示例
           

摘要

Background. There is limited knowledge regarding progressive resistance training during adjuvant chemotherapy and the risk of developing breast cancer-related lymphedema (BCRL). Furthermore, no studies have investigated the safety of resistance training with heavy loads (>80% 1 repetition maximum) in this population. 'Body and Cancer' is a six-week, nine-hour weekly, supervised, multimodal exercise intervention utilizing progressive resistance training with heavy loads for cancer patients undergoing chemotherapy. The purpose of the present study was to estimate the prevalence of BCRL in former participants, and identify associations between progressive resistance training with heavy loads, and the development of BCRL. Material and methods. This was a descriptive study. Population: Women treated for breast cancer (n = 149), who had participated in the 'Body and Cancer' exercise intervention between 1 January 2010 and 31 December 2011 participated in a structured telephone interview. The average follow-up time was 14 months (range 4 26). A clinical diagnosis of BCRL reported by the participant was the primary outcome. Results. A total of 27.5% reported that they had been diagnosed with BCRL by a clinician. This was true for 44.4% with axillary node dissection. No statistically significant association between strength gains during the exercise intervention, and the development of BCRL was observed, nor was self-reported participation in progressive resistance training with heavy loads up to three months post-intervention. Conclusion. The prevalence of BCRL among former "Body and Cancer" participants at follow-up was 27.5%. There appears to be no association between performing heavy resistance training during adjuvant treatment (chemotherapy/radiotherapy), and the development of BCRL. However randomized controlled trials should be performed to confirm this observation.
机译:背景。关于辅助化疗期间进行性耐药训练以及发生与乳腺癌相关的淋巴水肿(BCRL)的风险的知识有限。此外,尚无研究调查此人群中重负荷(最大重复次数> 80%时)的阻力训练的安全性。 “身体与癌症”是每周六周,九小时,有监督的多模式运动干预,利用逐步的阻力训练和重负荷为正在接受化疗的癌症患者提供治疗。本研究的目的是评估以前参加者的BCRL患病率,并确定重负荷进行性抵抗训练与BCRL的发展之间的关联。材料与方法。这是一项描述性研究。人口:在2010年1月1日至2011年12月31日期间参加了“身体与癌症”运动干预措施的接受过乳腺癌治疗的妇女(n = 149)参加了一次结构性电话采访。平均随访时间为14个月(范围4 26)。参与者报告的BCRL临床诊断是主要结局。结果。共有27.5%的人报告说,他们已被临床医生诊断为BCRL。腋窝淋巴结清扫术的比例为44.4%。在运动干预过程中获得的力量增加与BCRL的发展之间没有统计学上的显着关联,也没有自我报告参与干预后三个月以内的重负荷进行性阻力训练。结论。在随访中,前“身体与癌症”参与者中BCRL的患病率为27.5%。在辅助治疗(化学疗法/放射疗法)期间进行重度抵抗训练与BCRL的发展之间似乎没有关联。但是,应该进行随机对照试验以确认这一观察结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号